Your browser doesn't support javascript.
loading
Cell-density independent increased lymphocyte production and loss rates post-autologous HSCT.
Baliu-Piqué, Mariona; van Hoeven, Vera; Drylewicz, Julia; van der Wagen, Lotte E; Janssen, Anke; Otto, Sigrid A; van Zelm, Menno C; de Boer, Rob J; Kuball, Jürgen; Borghans, Jose Am; Tesselaar, Kiki.
Afiliação
  • Baliu-Piqué M; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
  • van Hoeven V; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
  • Drylewicz J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
  • van der Wagen LE; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Janssen A; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Otto SA; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
  • van Zelm MC; Department of Immunology and Pathology, Monash University and Alfred Hospital, Melbourne, Australia.
  • de Boer RJ; Theoretical Biology, Utrecht University, Utrecht, Netherlands.
  • Kuball J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Borghans JA; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Tesselaar K; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.
Elife ; 102021 02 04.
Article em En | MEDLINE | ID: mdl-33538246
ABSTRACT
Lymphocyte numbers need to be quite tightly regulated. It is generally assumed that lymphocyte production and lifespan increase homeostatically when lymphocyte numbers are low and, vice versa, return to normal once cell numbers have normalized. This widely accepted concept is largely based on experiments in mice, but is hardly investigated in vivo in humans. Here we quantified lymphocyte production and loss rates in vivo in patients 0.5-1 year after their autologous hematopoietic stem cell transplantation (autoHSCT). We indeed found that the production rates of most T- and B-cell subsets in autoHSCT-patients were two to eight times higher than in healthy controls, but went hand in hand with a threefold to ninefold increase in cell loss rates. Both rates also did not normalize when cell numbers did. This shows that increased lymphocyte production and loss rates occur even long after autoHSCT and can persist in the face of apparently normal cell numbers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante Autólogo / Linfócitos / Contagem de Linfócitos / Transplante de Células-Tronco Hematopoéticas Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Elife Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante Autólogo / Linfócitos / Contagem de Linfócitos / Transplante de Células-Tronco Hematopoéticas Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Elife Ano de publicação: 2021 Tipo de documento: Article